X4 Pharmaceuticals Cash from Financing (Quarterly) Analysis

X4 Pharmaceuticals Inc (XFOR)

1.015 +0.04 (+4.01%) USD | NASDAQ | May 31, 16:00

1.02 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	0.00
December 31, 2023	0.097M
September 30, 2023	21.20M
June 30, 2023	69.34M
March 31, 2023	-2.124M
December 31, 2022	60.64M
September 30, 2022	51.98M
June 30, 2022	-0.347M
March 31, 2022	4.956M
December 31, 2021	24.57M
September 30, 2021	-4.442M
June 30, 2021	-0.924M
March 31, 2021	55.04M
December 31, 2020	7.629M
September 30, 2020	-0.284M

Date	Value
June 30, 2020	0.065M
March 31, 2020	4.984M
December 31, 2019	60.28M
September 30, 2019	-6.414M
June 30, 2019	86.68M
March 31, 2019	0.113M
December 31, 2018	8.511M
September 30, 2018	-0.583M
June 30, 2018	-0.432M
March 31, 2018	-0.626M
December 31, 2017	58.35M
September 30, 2017	3.639M
June 30, 2017	34.94M
March 31, 2017	4.336M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-6.414M

Minimum

Sep 2019

86.68M

Maximum

Jun 2019

21.65M

Average

4.97M

Median

Cash from Financing (Quarterly) Benchmarks

Phio Pharmaceuticals Corp	-0.004M
Ocular Therapeutix Inc	321.22M
Alpine Immune Sciences Inc (DELISTED)	19.35M
Scholar Rock Holding Corp	6.525M
RAPT Therapeutics Inc	9.036M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-33.60M
Cash from Investing (Quarterly)	-5.322M
Free Cash Flow	-103.71M
Free Cash Flow Per Share (Quarterly)	-0.1683
Free Cash Flow Yield	-53.44%